IGC Pharma, Inc. (FRA:IGS1)

IGC Pharma Revenue

IGC Pharma had revenue of $191.00K USD in the quarter ending September 30, 2025, a decrease of -53.64%. This brings the company's revenue in the last twelve months to $1.11M, down -6.51% year-over-year. In the fiscal year ending March 31, 2025, IGC Pharma had annual revenue of $1.27M, down -5.50%.

• Revenue (ttm): $1.11M
• Revenue Growth: -6.51%
• P/S Ratio: 27.11
• Revenue / Employee: $15.80K
• Employees: 70
• Market Cap: 25.56M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.27M	-74.00K	-5.50%
Mar 31, 2024	1.35M	434.00K	47.64%
Mar 31, 2023	911.00K	514.00K	129.47%
Mar 31, 2022	397.00K	-501.00K	-55.79%
Mar 31, 2021	898.00K	-3.17M	-77.95%
Mar 31, 2020	4.07M	-1.04M	-20.41%
Mar 31, 2019	5.12M	2.92M	133.29%
Mar 31, 2018	2.19M	1.61M	277.86%
Mar 31, 2017	580.37K	-5.79M	-90.88%
Mar 31, 2016	6.37M	-1.31M	-17.10%
Mar 31, 2015	7.68M	5.41M	237.87%
Mar 31, 2014	2.27M	-5.76M	-71.69%
Mar 31, 2013	8.03M	3.83M	91.21%
Mar 31, 2012	4.20M	125.63K	3.08%
Mar 31, 2011	4.07M	-13.82M	-77.24%
Mar 31, 2010	17.90M	-17.44M	-49.35%
Mar 31, 2009	35.34M	33.15M	1,515.10%
Mar 31, 2008	2.19M	-	-